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ABSTRACT
Aims: A cardiopulmonary exercise test (CPET) is the gold standard to evaluate symptom-limiting exercise
intolerance, while continuous laryngoscopy performed during exercise (CLE) is required to diagnose
exercise-induced laryngeal obstruction. Combining CPET with CLE would save time and resources;
however, the CPET data may be distorted by the extra equipment. We therefore aimed to study whether
CPET with CLE influences peak oxygen uptake (V′O2peak) and other gas exchange parameters when
compared to a regular CPET.
Methods: Forty healthy athletes without exercise-related breathing problems, 15–35 years of age,
performed CPET to peak exercise with and without an added CLE set-up, in randomised order 2–4 days
apart, applying an identical computerised treadmill protocol.
Results: At peak exercise, the mean difference (95% confidence interval) between CPET with and without
extra CLE set-up for V′O2peak, respiratory exchange ratio (RER), minute ventilation (V′E) and heart rate
(HR) was 0.2 (−0.4 to 0.8) mL·kg−1·min−1, 0.01(−0.007 to 0.027) units, 2.6 (−1.3 to 6.5) L·min−1 and 1.4
(−0.8 to 3.5) beats·min−1, respectively. Agreement (95% limits of agreement) for V′O2peak, RER and V′E
was 0.2 (±3.7) mL·kg−1·min−1, 0.01 (±0.10) units and 2.6 (±24.0) L·min−1, respectively. No systematic or
proportional bias was found except for the completed distance, which was 49 m (95% CI 16 to 82 m)
longer during CPET.
Conclusion: Parameters of gas exchange, including V′O2peak and RER, obtained from a maximal CPET
performed with the extra CLE set-up can be used interchangeably with data obtained from standard
CPET, thus preventing unnecessary additional testing.
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Exercise-related breathing problems are common, with causes varying from poor physical condition,
overweight or de-training, to disease conditions such as respiratory or cardiac disorders [1]. Asthma and
exercise-induced bronchoconstriction are important causes of exercise-related breathing problems; however,
the significance of exercise-induced laryngeal obstruction (EILO) is increasingly acknowledged [2]. With a
prevalence of 5–7% in unselected adolescent populations [3, 4], and even higher in groups where exercise is
particularly important [5, 6], EILO is now recognised as an important cause of exertional breathlessness
[3, 7, 8]. We know that misdiagnosing exercise-related breathing problems might lead to unfortunate
consequences and delay institution of adequate treatment [9–12]. We also know that diagnostic evaluations
based solely on patients’ symptom descriptions are inaccurate, and guidelines therefore prescribe objective
evaluation [13]. Despite good intentions, diagnostic errors are made, often because objective tests are not
performed [5, 14–17].
A cardiopulmonary exercise test (CPET) is the gold standard for evaluating symptom-limiting exercise
intolerance in patients with suspected respiratory or cardiac disease [18]. Continuous laryngoscopy exercise
(CLE) testing is the gold standard for diagnosing EILO and requires flexible video laryngoscopy performed
during a maximal CPET [8, 19]. Combining CPET and CLE on a treadmill was first performed by our
research group, published in 2006 [20]. This combined set-up has benefits in clinical and scientific
situations, enabling comprehensive physiological evaluations of gas exchange, and cardiovascular and
respiratory capacities and limitations, in addition to concomitant visual assessment of the larynx [1].
Measurement of maximal oxygen consumption (V′O2) based on a standard CPET is highly reproducible [21].
The combined set-up of CPET and CLE represents more stress for the patient, adds extra weight, and can
introduce air leaks, all of which might influence performance and gas exchange. MIRZA et al. [22] found
no systematic difference between important parameters of gas exchange obtained from bicycle CPETs
performed with and without continuous laryngoscopy. We aimed to expand on that knowledge, and
conducted a full method comparison study using treadmill exercise, evaluating reliability and the upper
and lower limits of agreement between peak oxygen consumption (V′O2peak) and other parameters of gas
exchange obtained from a CPET with and without added CLE equipment.
Material and methods
Subjects and study design
In this method comparison study, a convenience sample of healthy 15–35-year-old athletes participating in
endurance training for a minimum of four times per week, were recruited to perform CPET to peak
exercise, with and without added CLE set-up, in a randomised order. The two tests were performed
2–4 days apart applying the same computerised treadmill protocol. Except for the modifications required
for the CLE test, the equipment and the pre-test preparations were identical. The test personnel consisted
of three people, providing instructions and encouragement in similar ways.
At inclusion, all participants completed a questionnaire on past medical history and habits of physical
activity and exercise. Subjects who reported breathing difficulties at rest or during exercise, or who had any
medical issues (except well-controlled asthma) were not enrolled. Information on the use of nicotine, food
intake, hours of nightly sleep, time of previous workout, or any symptoms of illness were obtained for the
24 h preceding both tests.
Pulmonary function
Spirometry was performed on both test days, using a Vyntus PNEUMO spirometer (Vyaire Medical
GmbH, Leibnizstrasse, Hoechberg, Germany) according to guidelines [23]. Forced vital capacity (FVC)
and forced expiratory volume in 1 s (FEV1) were recorded and reported as raw data and as z-scores
calculated by the Global Lung Function Initiate online calculator [24].
CPET
An incremental treadmill (Woodway PPS 55 Med, Weil am Rhein, Germany) test was applied, using a
pre-set modified Bruce protocol [25]. Speed and elevation were gradually increased every 60 s from an
initial slow walking phase. A facemask (Hans Rudolph Inc., Kansas City, MO, USA) connected the patient
to a Vyntus CPX unit powered by SentrySuite software (Vyaire Medical GmbH, Leibnizstrasse, Hoechberg,
Germany). After baseline variables were established, subjects ran to exhaustion. Parameters of gas
exchange and airflow were measured breath-by-breath and averaged over 30 s.
The test was considered successful when the subjects indicated exhaustion, preferably supported by a
plateau in V′O2 and/or the heart rate (HR) response. Duration and completed treadmill distance were
recorded. V′O2, carbon dioxide output (V′CO2), tidal volume (VT), respiratory rate (RR) and HR were
measured directly, while minute ventilation (V′E) was calculated from VT and RR.
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CLE test
The CPET part of the CLE test was performed as described above. After application of local anaesthesia
(Lidocaine), a flexible fibreoptic laryngoscope (Olympus ENF-V2, Tokyo, Japan) with diameter 3.4 mm
was introduced into the pharyngeal space via a tight-fit opening in a slightly modified Hans Rudolph
facemask and through one nostril (figure 1). The mask was tested for air leaks and the laryngoscope was
secured with tape and positioned for a good view of the laryngeal entrance, including supraglottic
structures and the vocal folds. The body of the laryngoscope was secured to the head of the test person by
custom-made headgear. During the treadmill test, the added CLE equipment allowed for videorecording of
the laryngeal inlet (figure 1).
Analysis
Data were reported as means with 95% confidence intervals, ranges or SD for continuous data or counts
with percentages for categorical data. Cardiopulmonary exercise data from tests without the CLE set-up
were labelled “CPET”, whereas data from tests with the added CLE set-up were labelled “CLE”. A paired
t-test was used to compare mean differences.
An intraclass correlation coefficient (ICC) using a two-way mixed effect model based on single ratings was
calculated to assess the absolute agreement of the repeated measurements at peak exercise; V′O2peak,
V′CO2peak, respiratory exchange ratio (RER), RR, HR, VT and V′E. Values >0.6 were considered to indicate
good reliability, and values >0.9 to indicate excellent reliability [26]. To assess the reproducibility of the
data, the within-subject coefficients of variation (CoV) for the parameters were calculated assuming that
the SD was reasonably constant across the concentration intervals.
Agreement between the ergospirometry data produced by the CPET and CLE method was assessed by
calculating the SD of the mean difference between the measurements obtained with the two techniques.
The SD was used to calculate 95% limits of agreement (LoA) between the two techniques, representing
±1.96 SD of the differences [27]. Results were expressed as values and percentages of the average of the
paired differences and visualised in Bland–Altman plots for V′O2peak, RER and V′E. We considered
3.5 mL·kg−1·min−1 to be the maximum acceptable difference within pairs of peak V′O2 measurements,
equivalent to one metabolic equivalent of task. One-sample t-test versus zero was used to examine for a
systematic bias between the two methods. The differences between the two methods were regressed on
their average to test for proportional bias (i.e. if the differences were influenced by the numerical size of
the measurements). Normal distribution of the differences was verified by a Kolmogorov–Smirnov test.
The criterion for statistical significance was set at p<0.05. Statistical calculations were performed using the
statistical software SPSS version 25 (IBM SPPS Statistics, Armonk, NY, USA) and MedCalc version 19.5.3
(MedCalc Software Ltd., Osted, Belgium).
We used MedCalc statistical software to determine an appropriate sample size for agreement of peak V′O2
(α values set to 0.05 and power to 90%). A minimum of 31 pairs were required, providing an expected
mean difference of 0.4 mL·kg−1·min−1, an expected SD for the mean difference of 1.0 mL·kg−1·min−1, and
95% LoA set to 3.5 mL·kg−1·min−1.
Ethics
The Regional Committee for Medical and Health Research Ethics of the Western Norway Health
Authority approved of the study (REC 2014/601). Written informed consent was obtained from all
participants. For participants under 16 years, parents also signed the consent.
Results
Of 47 participants, 40 (21 females) successfully completed both the CPET and the CLE test. Their
characteristics are given in table 1 and the CPET results are summarised in table 2. Four of the seven
incomplete datasets represent participants who were declined further participation because of an asthma
exacerbation or for EILO symptoms discovered at the first test, one had difficulties running on the
treadmill, one could not find time for the second test, and one participant actively declined to perform the
repeat test.
Ergospirometry data obtained with or without the CLE set-up did not differ. The distance completed on
the treadmill was 49 m (95% CI 16 to 82 m) longer during CPET than during the CLE test (systematic
bias), but there was no proportional bias. For all other parameters, there was no systematic or proportional
bias (i.e. the data produced by the two methods did not systematically differ from each other), nor were
there differences between the measurements influenced by the size of their average.
Table 3 summaries the reliability and reproducibility of the parameters and figure 2 illustrates the
agreement for V′O2peak, V′E and RER in Bland–Altman plots. For V′O2peak the mean difference (95%
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FIGURE 1 Illustration of the set-up for cardiopulmonary exercise test (CPET) with and without continuous
video laryngoscopy. The upper left and right images demonstrate the facemask used for ordinary CPET. The
middle left and right images demonstrate the modified facemask with a flexible transnasal laryngoscope
positioned through a tight-fit opening. A custom-made headgear secures the body of the laryngoscope. The
attached transnasal flexible laryngoscope enables video recording of the laryngeal inlet during the maximal
exercise treadmill test (bottom image).
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LoA) was 0.2 (±3.7) mL·kg−1·min−1, and the ICC was excellent with a low CoV (table 3 and figure 2). For
V′E at peak exercise the mean difference (95% LoA) was 2.6 (±24) L·min−1, the ICC was excellent, and the
CoV was low. For RER, the agreement was good and the ICC was fair with a low CoV (table 3 and figure 2).
Discussion
This is the first study to establish the LoA between parameters of gas exchange obtained during maximal
cardiopulmonary treadmill exercise with and without concurrent laryngoscopy, performed in physically
active and healthy subjects. The study indicates that the CLE equipment does not disturb the CPET
measurements. CPET and CLE tests are time- and resource-consuming for patients and healthcare
providers. Combining the two saves time and ensures that advanced patient evaluation can be performed
at lower personal and financial costs.
Our findings are consistent with the only similar study comparing CPET with and without CLE; however,
the other study by MIRZA et al. [22] was performed in sedentary or moderately physically active individuals
with EILO, using a cycle ergometer. They found a mean (95% CI) difference in V′O2peak of 22 (−125 to
81) mL·min−1, compared to our results of 11 (−33 to 56) mL·min−1. MIRZA et al. [22] did not report the
degree of expected agreement between the gas exchange parameters obtained with the two methods.
TABLE 1 Characteristics of the 40 subjects comparing peak oxygen consumption measured
with or without continuous laryngoscopy during cardiopulmonary exercise test on a treadmill
Female sex n (%) 21 (53)
Age years mean (range) 24.8 (15.0 to 35.0)
BMI kg·m−2 22.3±2.3
Smoking n (%) 0 (0)
Exercise
4–6 days per week n (%) 19 (47.5)
Daily n (%) 21 (52.5)
Asthma n (%) 1 (3)
FVC CPET L 5.12±1.26
FVC CLE L 5.15±1.25
FVC z-score CPET 0.25±0.81
FVC z-score CLE 0.30±0.79
FEV1 CPET L 4.31±1.32
FEV1 CLE L 4.20±0.92
FEV1 z-score CPET 0.05±0.83
FEV1 z-score CLE 0.07±0.79
Data are presented as mean±SD, unless otherwise stated. BMI: body mass index; FVC: forced vital
capacity; CPET: cardiopulmonary exercise test; CLE: continuous laryngoscopy during exercise; FEV1:
forced expiratory volume in 1 s.
TABLE 2 Ergospirometry data for the 40 participants obtained from cardiopulmonary exercise tests performed without and
with added CLE test set-up
Parameter CPET without CLE CPET with CLE Difference
Mean SD Mean SD Mean (95% CI)
V′O2peak mL·min−1 3818 873.8 3806 883.4 11.4 (−33.5, 56.2)
V′O2peak mL·kg−1·min−1 54.9 6.3 54.7 6.6 0.22 (−0.40, 0.83)
V′CO2peak mL·min−1 4618 1016 4565 1006 53.1 (−25.9, 132.0)
VT L 2.61 0.65 2.61 0.62 0.005 (−0.08, 0.071)
V′E L·min−1 142.3 33.1 139.7 34.2 2.58 (−1.33, 6.49)
HR beats·min−1 186 8.7 185 9.0 1.4 (−0.8, 3.5)
RR breaths·min−1 55 9.3 54 10.0 1.2 (−1.5, 4.0)
RER units 1.21 0.05 1.20 0.05 0.01 (−0.007, 0.027)
Distance m 1199 219 1150 210 49 (15.7, 82.0)
CLE: continuous laryngoscopy during exercise; CPET: cardiopulmonary exercise test; V′O2peak: oxygen consumption at peak exercise;
V′CO2peak: carbon dioxide production at peak exercise; VT: tidal volume; V′E: minute ventilation; HR: heart rate; RR: respiratory rate; RER:
respiratory exchange rate.
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We opted to apply a treadmill protocol, aiming to achieve the highest possible effort of the subjects.
Treadmill exercise has proven feasible in subjects not familiar with exercise testing in general [28] and it is
our experience that children and adolescents more often exercise to exhaustion on a treadmill than on a
cycle ergometer. Moreover, running involves larger muscle masses and leads to a greater stress on the
organ systems mediating the exercise response, generally leading to 5–10% higher maximal oxygen
consumption [29, 30]. This might be of importance in athletes, and in some patients where abnormalities
may occur only at high metabolic demands, which could be the case for patients with symptoms
resembling EILO [29].
V′O2peak is the most important CPET parameter for determining cardiorespiratory fitness and it is
commonly used as a primary end-point for studies to determine the effect of therapeutic interventions or
training programmes [31]. DECATO et al. [32] provide an overview of studies reporting repeatability of
CPET variables both for normal subjects and chronically ill patients. For V′O2peak, the CoV ranges from
3.0% to 13% [33, 34] and large studies using highly consistent exercise test methodology found CoVs of
4.9 to 5.1% [32, 35]. Heterogeneities between studies represent technical errors, technicians with varying
experiences, and different exercise protocols in addition to biological variation [36]. In our study there was
no systematic bias favouring any of the two methods, and the CoV of V′O2peak measurements was only
2.5% (i.e. a value below what is reported for repeat CPETs). This steadiness may be due to our test
TABLE 3 Reliability and reproducibility of the ergospirometry data obtained for the 40 participants performing
cardiopulmonary exercise test with and without CLE test set-up
Parameter Agreement Lower LoA Upper LoA ICC (95% CI) WS-SD CoV %
V′O2peak mL·min−1 11.4 −263 286 0.988 (0.977, 0.993) 98 2.6
V′O2peak mL·kg−1·min−1 0.2 −3.5 4.0 0.957 (0.920, 0.977) 1.3 2.5
V′CO2peak mL·min−1 53.1 −431 537 0.970 (0.943, 0.984) 176 3.8
VT L 0.0 −0.47 0.46 0.933 (0.876, 0.964) 0.16 6.3
V′E L·min−1 2.6 −21.4 26.5 0.933 (0.877, 0.964) 8.7 6.2
HR beats·min−1 1.4 −11.6 14.3 0.720 (0.532, 0.841) 4.7 2.5
RR breaths·min−1 −2.5 −19.9 15.0 0.614 (0.375, 0.777) 6.0 11.1
RER units 0.01 −0.09 0.11 0.502 (0.233, 0.700) 0.04 3.1
CLE: continuous laryngoscopy during exercise; LoA: limit of agreement; ICC: intraclass correlation coefficient; WS-SD: within-subject SD; CoV:
coefficient of variation; V′O2peak: oxygen consumption at peak exercise; V′CO2peak: carbon dioxide production at peak exercise; VT: tidal volume;























































































































FIGURE 2 Agreement between peak oxygen consumption (V′O2peak), respiratory exchange ratio (RER) and minute ventilation (V′E) obtained from
cardiopulmonary exercise testing (CPET) and continuous laryngoscopy performed during exercise (CLE) test. The horizontal lines depict the mean
difference between the variables obtained with the two methods, whereas ±1.96 SD of these differences represent 95% limits of agreement
between the two methods. The 95% confidence intervals for the mean, the upper limit of agreement and the lower limit of agreement are
indicated by vertical lines. The figures given below in the brackets are the mean difference and the upper and lower limits of agreement,
expressed as percentages of the mean of the CPET and CLE value. a) Agreement between V′O2peak, expressed as mL·kg
−1·min−1, obtained from
CPET and CLE tests. The mean difference was 0.2 mL·kg−1·min−1 (0.4%), the upper limit of agreement was 4.0 mL·kg−1·min−1 (7.0%), and the
lower limit of agreement was −3.5 mL·kg−1·min−1 (−6.2%). b) Agreement between RER obtained from CPET and CLE test at peak exercise. The
mean difference was 0.01 units (0.7%), the upper limit of agreement was 0.11 units (9.2%), and the lower limit of agreement was −0.09 units
(−7.8%). c) Agreement between V′E obtained from CPET and CLE test at peak exercise. The mean difference was 2.58 L·min−1 (2.2%), the upper
limit of agreement was 26.5 L·min−1 (18.3%), and the lower limit of agreement was −21.4 L·min−1 (−13.9%).
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population, consisting of athletes who conceivably are more used to repeatedly performing to their peak
exercise capacity than average sedentary individuals.
The CoV of the parameters V′E, RER, and HR in the present study were generally consistent with or lower
than previous reports from repeatability studies of CPET without CLE [32]. The ICCs for V′E and HR
were excellent and good, respectively. The ICC for RER was not as good as the other parameters, which
may be explained by the diurnal variation of this parameter as the participants were not scheduled for
testing at the same hours of the day [32]. The mean completed distance was 49 m longer for the test
without the CLE set-up, yet achieving the same V′O2peak. This result could be explained by the added
weight and higher work of breathing with one nostril occlude by the laryngoscope, although this
assumption is uncertain, and we cannot provide a good explanation. Regarding peak V′E, LoA was
relatively wide and in the area of 15% of its mean value, which is in line with studies testing repeatability
of CPET [32]. Peak V′E is included in the calculation of a patient’s breathing reserve, which is used to
identify ventilatory limitation to exercise. Based on the result from this study, caution should be exercised
if a ventilatory limitation to exercise is established solely on the interpretation of a reduced breathing reserve.
CPET is considered the gold standard for evaluating symptom-limited exercise tolerance in patients with
pulmonary and cardiac disease [18]. Although response patterns obtained from CPET are not necessarily
disease-specific, they nevertheless contribute to the diagnostic process of narrowing down the spectrum of
differential diagnoses. Normal CPET response patterns are usually taken as evidence against significant
involvement of these systems in exercise limitation. Combining CPET with the CLE test is valuable in
several ways. The most obvious advantage is that exercise-induced changes of the laryngeal configuration
can be evaluated against corresponding changes of gas exchange parameters. This can be of value in the
understanding of individual patients’ limitations, as well as facilitate a better understanding of the
phenomenon of EILO in research, such as providing outcome measures in intervention studies that aim to
improve EILO. Moreover, CPET data will identify if patients reach their maximum level of effort and can
serve to identify abnormalities in the oxygen transport pathways, irrespectively of obstructions in the
larynx. Lastly, if no signs of abnormalities are revealed, the CPET data inform that the patient’s dyspnoea
is not likely to be associated with an abnormal physiological limitation, but instead consistent with the
actual physical fitness of the tested individual.
Finding a normal V′O2peak may be helpful in providing reassurance to patients and prevent unnecessary
subsequent testing and evaluations. However, it is important to bear in mind that CPET results should be
interpreted based on expected values for the population under investigation [29, 37]. Therefore, it is
important to ensure that the gas exchange parameters obtained from a CLE test are correct also in
physically active individuals, as shown by this study.
Strength and limitations
The major strengths of this study were the randomised crossover design and the relatively high number of
participants performing endurance training at a high level. Measuring V′O2peak may be influenced by a
learning effect, and performing the tests in randomised order controlled for this possible bias [29].
All our participants were highly physically active performing endurance training at least four times per
week with no reports of breathing problems. Their familiarity with high-level training and performance
likely reduced the variation between the two tests. Moreover, other studies testing reproducibility of
V′O2peak have used shorter test protocols and longer “between-test” periods of up to 30 days compared to
our maximum of 2 weeks [32].
We did not systematically collect information on previous experiences with exercise testing, flexible
laryngoscopy, or CLE testing prior to inclusion. This is a limitation to the study as familiarity with the test
situation can influence the results. In the records from our test laboratory, we found that prior to the
study, six subjects had performed a CPET test and none had performed a CLE test. The distance to the
next cardiopulmonary laboratory capable of performing a CLE test is 600 km. Thus, we find it unlikely
that any of these healthy participants had performed a CLE test prior to this study.
Testing only healthy athletic subjects without respiratory complaints, challenges the validity for patients
who undergo cardiopulmonary exercise testing for reasons other than EILO. On the other hand, this
limitation represents a strength in the context of testing patients with EILO, as EILO is common in
athletes and physically active individuals [5]. The test personnel were not technically prevented from
access to previous results, and access to such knowledge could in theory have influenced their level of
encouragement during the second test. However, the test personnel were skilled and experienced
researchers who did in fact not access the previous test results. We did not collect information on how the
added laryngoscope influenced perceived dyspnoea or discomfort during test, and we did not use a Borg
score or other dyspnoea or discomfort scores. Ultimately, dyspnoea or breathing difficulties during exercise
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are the main reason for performing a CPET with CLE, and future studies should explore the added
discomfort imposed by the extra necessary gear.
The 95% LoA between V′O2peak obtained from CPET with and without CLE was 0.2 ±3.7 mL·kg
−1·min−1,
which was slightly higher than the 3.5 mL·kg−1·min−1 that we had considered clinically relevant. This was
due to the SD of the mean difference being larger than expected, which could have been moderated by
including more participants. However, inclusion was complicated by active young people with tight
schedules, a busy exercise test laboratory, and a test protocol that prescribed replicate testing within
2 weeks.
In conclusion, V′O2peak and most of the other ergospirometry data obtained from a CLE test can be used
interchangeably with data obtained from a standard CPET in athletes and highly physically trained
individuals. Thus, we recommend performing CPET with CLE set-up, if available, when assessing patients
with unexplained exertional breathing problems.
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